https://www.selleckchem.com/pr....oducts/GSK461364.htm
Kenya, 2012-2015. To explore whether there is a gender difference in all-cause mortality among smear positive pulmonary tuberculosis (PT/ HIV co-infected patients treated for tuberculosis (T between 2012 and 2015 in Kenya. Retrospective cohort of 9,026 smear-positive patients aged 15-49 years. All-cause mortality during TB treatment was the outcome of interest. Time to start of antiretroviral therapy (ART) initiation was considered as a proxy for CD4 cell count. Those who took long to start of ART were assumed to have high CD4 cel
Like
Comment
Share
